IVFAustralia Selects Cryoport as Exclusive Supply Chain Solutions Provider
SYDNEY and NASHVILLE, Tenn., June 29, 2023 /PRNewswire/ -- IVFAustralia , an Australian-based provider of full-service fertility care, IVF and related services as part of the Virtus Health network, and Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative temperature-controlled supply chain solutions supporting the life sciences, reproductive medicine and animal health industries, today announced that IVFAustralia has selected Cryoport as its exclusive supply chain solutions partner for its global reproductive material shipments.
- SYDNEY and NASHVILLE, Tenn., June 29, 2023 /PRNewswire/ -- IVFAustralia , an Australian-based provider of full-service fertility care, IVF and related services as part of the Virtus Health network, and Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a leading global provider of innovative temperature-controlled supply chain solutions supporting the life sciences, reproductive medicine and animal health industries, today announced that IVFAustralia has selected Cryoport as its exclusive supply chain solutions partner for its global reproductive material shipments.
- The multi-year agreement provides IVFAustralia and its fertility patients with the most advanced cryogenic shipping service in the world.
- "IVFAustralia is at the forefront of innovations that ensure risk mitigation for our patients," said Kate Munnings, CEO of Virtus Health.
- "Always employing the latest technologies and in keeping with the Fertility Society of Australia and New Zealand's issued recommendations around advanced data logging, chain of custody and condition monitoring that should be followed while transporting cryopreserved gametes and embryos, we have chosen Cryoport as our exclusive supply chain solutions provider.